Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoantibodies against small nuclear ribonucleoprotein components.

W J van Venrooij

    The Journal of Rheumatology. Supplement
    |June 1, 1987
    PubMed
    Summary

    Autoantibodies in rheumatic diseases target small nuclear ribonucleoprotein (snRNP) particles. These antibodies are crucial tools for understanding snRNP structure and function, aiding in disease research.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intracellular amino acids and protein synthesis in Hela cells.

    Molecular biology reports·2013
    Same author

    Autoantibody testing in the evaluation of idiopathic inflammatory myopathies: myositis-specific autoantibodies: are they ready to leave the bench for the bedside?

    Journal of clinical neuromuscular disease·2008
    Same author

    [The diagnostic accuracy of anti-citrulline antibody assessment in the diagnosis of patients suspected of rheumatoid arthritis by a general practitioner].

    Nederlands tijdschrift voor geneeskunde·2008
    Same author

    Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?

    Annals of the rheumatic diseases·2006
    Same author

    Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.

    Annals of the rheumatic diseases·2006
    Same author

    Long-term outcome in polymyositis and dermatomyositis.

    Annals of the rheumatic diseases·2006

    Area of Science:

    • Molecular Biology
    • Immunology
    • Rheumatology

    Background:

    • Systemic rheumatic diseases frequently exhibit autoantibodies against nuclear antigens.
    • Small nuclear ribonucleoprotein (snRNP) particles, composed of small nuclear RNA (snRNA) and associated proteins, are common targets.

    Purpose of the Study:

    • To characterize three classes of autoantibodies targeting snRNP particles.
    • To explore the utility of these autoantibodies in studying snRNP structure and function.
    • To investigate protein-RNA interactions within the U2 snRNP particle.

    Main Methods:

    • Characterization of autoantibody specificities against U1, Sm, and U2 snRNP associated proteins.
    • Analysis of U2 snRNP structure using mutant U2 snRNA and monospecific antibodies.
    • Isolation of recombinant clones encoding snRNP-associated proteins.

    Main Results:

    • Defined three distinct autoantibody classes: anti-(U1)RNP, anti-Sm, and anti-(U1,U2)RNP, with specific protein targets.
    • Demonstrated the utility of these autoantibodies as tools for snRNP research.
    • Initiated the molecular cloning of genes encoding snRNP proteins.

    Conclusions:

    • Autoantibodies against snRNPs are valuable reagents for investigating snRNP biogenesis and function.
    • Further research can leverage these antibodies and molecular tools to elucidate snRNP roles in health and disease.

    Related Experiment Videos